Chemoradiation in combination with trastuzumab and pertuzumab in operable esophageal carcinoma

Registry ID
EUCTR2013-004111-42
Source registry
EUCTR
Status
Completed
Phase
PHASE2
Sponsor
Academic Medical Center
Start date
2014-01-03
Last update
2026-08-16

Conditions

Summary

assess the feasibility of preoperative treatment with pertuzumab and trastuzumab combined with preoperative chemoradiation (carboplatin, paclitaxel and radiation) in terms of withdrawal rate from surgery

Locations

View on source registry